Two Sigma Securities’s Connect Biopharma Holdings CNTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,307
Closed -$14.5K 3046
2023
Q4
$14.5K Buy
+12,307
New +$14.6K ﹤0.01% 2769

Other funds holding CNTB

Two Sigma Securities's CNTB Position: Q1 2024 in Review

Two Sigma Securities sold out of Connect Biopharma Holdings (CNTB) in Q1 2024, closing a stake of 12,307 shares — an estimated $14.5K sold.

Two Sigma Securities first reported a position in CNTB in Q4 2023 and held it in 1 quarter. The position peaked at $14.5K in Q4 2023. 12 funds tracked by Wall St. Rank hold CNTB as of Q1 2024.

  • Two Sigma Securities reported no remaining Connect Biopharma Holdings position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 12,307 Connect Biopharma Holdings shares in Q1 2024, an estimated $14.5K.
  • Two Sigma Securities first reported a position in Connect Biopharma Holdings in Q4 2023 and held it in 1 quarter.
  • Two Sigma Securities's Connect Biopharma Holdings position peaked at $14.5K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.